F Hoffmann - Roche Holding Insider

Roche Holding AG -- USA Stock  

USD 240.25  12.45  4.93%

IR Contact Officer

We currently do not have informatin regarding F Hoffmann. This executive tanure with Roche Holding AG is not currenlty determined.
  Executive Since 2014      
41 61 688 11 11  http://www.roche.com

Management Efficiency

The company has return on total asset (ROA) of 15.0 % which means that it generated profit of $15.0 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 42.46 % meaning that it generated $42.46 on every $100 dollars invested by stockholders.
The company has accumulated 22.28 B in total debt with debt to equity ratio (D/E) of 83.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Roche Holding AG has Current Ratio of 1.26 suggesting that it may have difficulties to pay its financial obligations in time and when they become due.

Similar Executives

Found 2 records

EXECUTIVE Since

Cristina GilFernandezMetro Pacific Investments Corpo
2013
Joseph LacsonMetro Pacific Investments Corpo
2016

Entity Summary

Roche Holding AG operates in the pharmaceuticals and diagnostics businesses worldwide. Roche Holding AG (RHHBF) is traded on OTC Market in USA. It is located in Basel, and employs 91,747 people.

Did you try this?

Run Equity Analysis Now
   

Equity Analysis

Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Hide  View All  Next  Launch Equity Analysis
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Roche Holding AG to your portfolio

Top Management

Roche Holding AG Leadership Team
Osamu Nagayama, CEO
Michael Varney, Executive
Silvia Ayyoubi, Executive
Sophie KornowskiBonnet, Executive
Beatrice Mauro, Director
Cristina Wilbur, Executive
Roland Diggelmann, COO
Gottlieb Keller, Executive, Ph.D
Urs Jaisli, Executive
Daniel ODay, COO, MBA
DeAnne Julius, Director
Karl Mahler, Executive
Andre Hoffmann, Chairman, MBA
John Reed, Executive, Ph.D
Claudia Dyckerhoff, Director, Ph.D
Stephan Feldhaus, Executive, Ph.D
Julie Brown, Director
Richard Lifton, Director
Paul Bulcke, Director
Christoph Franz, Director
PerOlof Attinger, CEO
Pius Baschera, Director, Ph.D
Peter Voser, Director
Bernard Poussot, Director
John Bell, Director, Ph.D
Andreas Oeri, Director, Ph.D
Alan Hippe, CFO
F Hoffmann, Executive
Severin Schwan, CEO, Ph.D

Stock Performance

Roche Holding Performance Indicators